🔎 Trials Near Me

Početna › Multipla skleroza › New Jersey

Kliničke studije za Multipla skleroza u državi New Jersey

11 studija za Multipla skleroza traži sudionike na lokacijama u državi New Jersey.

Gradovi u državi New Jersey

Službeni tekst studije (engleski)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Rutgers Cancer Institute of New Jersey, New Brunswick
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Bridgewater
  • TG Therapeutics Investigational Trial Site, Cherry Hill
  • TG Therapeutics Investigational Trial Site, Freehold
  • i još 3
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Holy Name Medical Center- Site Number : 8400101, Teaneck
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Local Institution - 0131, New Brunswick
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT06408259

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

  • Novartis, East Hanover
U tijeku regrutacijaOpažajna studija
Od 18 do 100 godina · Oba spola · Ažurirano 21. kol 2026. · NCT07779460

A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis

  • Kessler Foundation, East Hanover
U tijeku regrutacija
Od 18 do 70 godina · Oba spola · Ažurirano 5. kol 2026. · NCT06197685

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

  • Bristol Myers Squibb, Lawrenceville
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 29. srp 2026. · NCT07732907

Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

  • Atlantic Health, Morristown
U tijeku regrutacijaFaza 4
Od 18 godina i više · Žene · Ažurirano 29. svi 2026. · NCT07614321

Multiple Sclerosis Implementation Network (Registry)

  • Multiple Sclerosis Association of America, Cherry Hill
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2026. · NCT07415824

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

  • Kessler Foundation, West Orange
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 24. stu 2025. · NCT04855825

Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community

  • Kessler Foundation, East Hanover
U tijeku regrutacija
Od 19 do 65 godina · Oba spola · Ažurirano 21. velj 2025. · NCT06608797

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.